Cellectis (CLLS) EPS (Basic) (2019 - 2023)
Historic EPS (Basic) for Cellectis (CLLS) over the last 5 years, with Q2 2023 value amounting to -$15.01.
- Cellectis' EPS (Basic) fell 350427.12% to -$15.01 in Q2 2023 from the same period last year, while for Jun 2023 it was -$15.01, marking a year-over-year decrease of 350427.12%. This contributed to the annual value of -$286.86 for FY2022, which is 3750506.53% down from last year.
- As of Q2 2023, Cellectis' EPS (Basic) stood at -$15.01, which was down 350427.12% from -$72.47 recorded in Q4 2022.
- In the past 5 years, Cellectis' EPS (Basic) ranged from a high of $42.73 in Q1 2020 and a low of -$72.47 during Q4 2022
- Its 5-year average for EPS (Basic) is -$18.88, with a median of -$22.05 in 2019.
- Over the last 5 years, Cellectis' EPS (Basic) had its largest YoY gain of 9877.95% in 2022, and its largest YoY loss of 3920945.45% in 2022.
- Cellectis' EPS (Basic) (Quarter) stood at -$29.08 in 2019, then plummeted by 45.96% to -$42.45 in 2020, then surged by 99.57% to -$0.18 in 2021, then plummeted by 39209.45% to -$72.47 in 2022, then surged by 79.29% to -$15.01 in 2023.
- Its last three reported values are -$15.01 in Q2 2023, -$72.47 for Q4 2022, and -$0.42 during Q2 2022.